{"transactions":[{"id":734195,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-18T00:30:12.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."}],"balance_after":1980,"derivative":{"underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001365619-26-000005","document":"form4-06172026_080608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000136561926000005/form4-06172026_080608.xml","form_type":"4"}},{"id":734194,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T00:30:12.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":3772,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting."}],"balance_after":3772,"derivative":{"exercise_price":101,"expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":3772},"source":{"system":"sec-edgar","filing":"0001365619-26-000005","document":"form4-06172026_080608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000136561926000005/form4-06172026_080608.xml","form_type":"4"}},{"id":734154,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T21:14:17.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder."}],"balance_after":16377,"derivative":{"exercise_price":35.59,"exercise_date":"2027-06-02","expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16377},"source":{"system":"sec-edgar","filing":"0001365619-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000136561926000004/primarydocument.xml","form_type":"4"}},{"id":739368,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-13T01:06:51.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":10891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":10891,"derivative":{"exercise_price":23.42,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":10891},"source":{"system":"sec-edgar","filing":"0001628280-26-043002","document":"wk-form4_1781312808.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000162828026043002/wk-form4_1781312808.xml","form_type":"4"}},{"id":739367,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T01:06:51.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":30120,"source":{"system":"sec-edgar","filing":"0001628280-26-043002","document":"wk-form4_1781312808.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000162828026043002/wk-form4_1781312808.xml","form_type":"4"}},{"id":757700,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:13.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders. The reporting person has elected to defer receipt of the shares of common stock underlying the restricted stock units until the earliest of the following: (i) the fifth anniversary of the date of grant of such restricted stock unit award; (ii) the date that is 30 days following the date on which the director ceases to serve as a member of the board of directors of the Issuer or otherwise provide services to the Issuer; and (iii) a change in control of the Issuer as defined in the Issuer's 2024 Equity Incentive Plan, as amended."}],"balance_after":9311,"derivative":{"underlying":"Common Stock","underlying_shares":9311},"source":{"system":"sec-edgar","filing":"0001365619-26-000002","document":"form4-06012026_060608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000136561926000002/form4-06012026_060608.xml","form_type":"4"}},{"id":757699,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-06-01T22:00:13.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":16004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":16004,"derivative":{"exercise_price":21.66,"expiration_date":"2036-05-28","underlying":"Common Stock","underlying_shares":16004},"source":{"system":"sec-edgar","filing":"0001365619-26-000002","document":"form4-06012026_060608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000136561926000002/form4-06012026_060608.xml","form_type":"4"}},{"id":757698,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001365619-26-000002","document":"form4-06012026_060608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000136561926000002/form4-06012026_060608.xml","form_type":"4"}},{"id":757697,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T22:00:13.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":8107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":23202,"source":{"system":"sec-edgar","filing":"0001365619-26-000002","document":"form4-06012026_060608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000136561926000002/form4-06012026_060608.xml","form_type":"4"}},{"id":1041647,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-13T00:00:09.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":15,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001415889-25-024463","document":"form4-09122025_080904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024463/form4-09122025_080904.xml","form_type":"4"}},{"id":1041646,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-13T00:00:09.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":1491,"price":75.07,"value":111929.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $75.07, and the range of prices were between $74.745 and $75.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":15703,"source":{"system":"sec-edgar","filing":"0001415889-25-024463","document":"form4-09122025_080904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024463/form4-09122025_080904.xml","form_type":"4"}},{"id":1041645,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-13T00:00:09.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":15509,"price":74.34,"value":1152939.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $74.34, and the range of prices were between $73.73 and $74.73. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":17194,"source":{"system":"sec-edgar","filing":"0001415889-25-024463","document":"form4-09122025_080904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024463/form4-09122025_080904.xml","form_type":"4"}},{"id":1041644,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-13T00:00:09.000Z","date":"2025-09-11","kind":"exercise","planned":false,"acquired":true,"shares":17000,"price":15,"value":255000.0,"ownership":{"direct":true},"balance_after":32703,"source":{"system":"sec-edgar","filing":"0001415889-25-024463","document":"form4-09122025_080904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925024463/form4-09122025_080904.xml","form_type":"4"}},{"id":1106351,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T23:37:28.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":14.68,"exercise_date":"2026-06-16","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-25-004961","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025004961/primarydocument.xml","form_type":"4"}},{"id":1111184,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:17:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":11279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":11279,"derivative":{"exercise_price":24.34,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":11279},"source":{"system":"sec-edgar","filing":"0001396814-25-000080","document":"wk-form4_1749845835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681425000080/wk-form4_1749845835.xml","form_type":"4"}},{"id":1111183,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:17:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":6163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":23715,"source":{"system":"sec-edgar","filing":"0001396814-25-000080","document":"wk-form4_1749845835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681425000080/wk-form4_1749845835.xml","form_type":"4"}},{"id":1121848,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-05T22:01:14.000Z","date":"2025-06-04","kind":"sale","planned":false,"acquired":false,"shares":14446,"price":21.78,"value":314633.88,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.77 through $21.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":15095,"source":{"system":"sec-edgar","filing":"0001415889-25-015832","document":"form4-06052025_060604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015832/form4-06052025_060604.xml","form_type":"4"}},{"id":1127751,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-02T23:36:44.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":3977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer."}],"balance_after":3977,"derivative":{"underlying":"Common Stock","underlying_shares":3977},"source":{"system":"sec-edgar","filing":"0001415889-25-015303","document":"form4-06022025_110641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015303/form4-06022025_110641.xml","form_type":"4"}},{"id":1127750,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T23:36:44.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting."}],"balance_after":6268,"derivative":{"exercise_price":44,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":6268},"source":{"system":"sec-edgar","filing":"0001415889-25-015303","document":"form4-06022025_110641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015303/form4-06022025_110641.xml","form_type":"4"}},{"id":1127749,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T23:36:44.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock unit vests on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-25-015303","document":"form4-06022025_110641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015303/form4-06022025_110641.xml","form_type":"4"}},{"id":1127748,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T23:36:44.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":5703,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":15703,"source":{"system":"sec-edgar","filing":"0001415889-25-015303","document":"form4-06022025_110641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925015303/form4-06022025_110641.xml","form_type":"4"}},{"id":1128187,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":8107,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001415889-25-015270","document":"form4-06022025_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015270/form4-06022025_060601.xml","form_type":"4"}},{"id":1128186,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2025-06-02T22:05:04.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":13793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":13793,"derivative":{"exercise_price":22.29,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":13793},"source":{"system":"sec-edgar","filing":"0001415889-25-015270","document":"form4-06022025_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015270/form4-06022025_060601.xml","form_type":"4"}},{"id":1128185,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:04.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-25-015270","document":"form4-06022025_060601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015270/form4-06022025_060601.xml","form_type":"4"}},{"id":1128184,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:05:04.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":9387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":29541,"source":{"system":"sec-edgar","filing":"0001415889-25-015270","document":"form4-06022025_060601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015270/form4-06022025_060601.xml","form_type":"4"}},{"id":1428941,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T12:25:46.000Z","date":"2024-08-16","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":12.81,"value":12810.0,"ownership":{"direct":true},"balance_after":17552,"source":{"system":"sec-edgar","filing":"0001396814-24-000117","document":"wk-form4_1724070340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681424000117/wk-form4_1724070340.xml","form_type":"4"}},{"id":1480309,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T22:12:35.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12179,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12179,"derivative":{"exercise_price":28.68,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":12179},"source":{"system":"sec-edgar","filing":"0001396814-24-000073","document":"wk-form4_1718316748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681424000073/wk-form4_1718316748.xml","form_type":"4"}},{"id":1480308,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-13T22:12:35.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":5230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 12, 2025, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":16552,"source":{"system":"sec-edgar","filing":"0001396814-24-000073","document":"wk-form4_1718316748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000139681424000073/wk-form4_1718316748.xml","form_type":"4"}},{"id":1482128,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T23:25:17.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":20594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders."}],"balance_after":20594,"derivative":{"exercise_price":17.13,"exercise_date":"2025-06-10","expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":20594},"source":{"system":"sec-edgar","filing":"0001562180-24-005019","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024005019/primarydocument.xml","form_type":"4"}},{"id":1486948,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-07T22:22:55.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2025 annual stockholder meeting."}],"balance_after":5703,"derivative":{"underlying":"Common Stock","underlying_shares":5703},"source":{"system":"sec-edgar","filing":"0001415889-24-016068","document":"form4-06072024_100651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016068/form4-06072024_100651.xml","form_type":"4"}},{"id":1486947,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T22:22:55.000Z","date":"2024-06-05","kind":"grant","planned":true,"acquired":true,"shares":8779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2025 annual stockholder meeting."}],"balance_after":8779,"derivative":{"exercise_price":26.3,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":8779},"source":{"system":"sec-edgar","filing":"0001415889-24-016068","document":"form4-06072024_100651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924016068/form4-06072024_100651.xml","form_type":"4"}},{"id":1497012,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:07.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":9387,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-24-015084","document":"form4-05312024_060502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015084/form4-05312024_060502.xml","form_type":"4"}},{"id":1497011,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2024-05-31T22:00:07.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":15959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":15959,"derivative":{"exercise_price":14.62,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":15959},"source":{"system":"sec-edgar","filing":"0001415889-24-015084","document":"form4-05312024_060502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015084/form4-05312024_060502.xml","form_type":"4"}},{"id":1497010,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:07.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001415889-24-015084","document":"form4-05312024_060502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015084/form4-05312024_060502.xml","form_type":"4"}},{"id":1497009,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T22:00:07.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":20154,"source":{"system":"sec-edgar","filing":"0001415889-24-015084","document":"form4-05312024_060502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015084/form4-05312024_060502.xml","form_type":"4"}},{"id":1851647,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:26:07.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12925,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12925,"derivative":{"exercise_price":38.74,"exercise_date":"2024-06-14","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12925},"source":{"system":"sec-edgar","filing":"0001209191-23-038014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123038014/doc4.xml","form_type":"4"}},{"id":1851646,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T21:26:07.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2024, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":11322,"source":{"system":"sec-edgar","filing":"0001209191-23-038014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123038014/doc4.xml","form_type":"4"}},{"id":1855946,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T23:29:09.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":22123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 12, 2023 will become vested on the earlier of (i) June 12, 2024 or (ii) the business day prior to the date of the 2024 annual meeting of stockholders."}],"balance_after":22123,"derivative":{"exercise_price":9.55,"exercise_date":"2024-06-12","expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":22123},"source":{"system":"sec-edgar","filing":"0001562180-23-005174","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218023005174/primarydocument.xml","form_type":"4"}},{"id":1855970,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-14T21:45:20.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2024 annual stockholder meeting."}],"balance_after":17000,"derivative":{"exercise_price":28.97,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-23-037127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123037127/doc4.xml","form_type":"4"}},{"id":1856368,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T21:14:46.000Z","date":"2023-06-12","kind":"sale","planned":true,"acquired":false,"shares":4500,"price":24.868,"value":111906.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $24.68 through $25.02, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein."}],"balance_after":13502,"source":{"system":"sec-edgar","filing":"0001209191-23-037106","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123037106/doc4.xml","form_type":"4"}},{"id":1863607,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T01:18:46.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":600,"price":38.74,"value":23244.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":9547,"source":{"system":"sec-edgar","filing":"0001209191-23-035254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123035254/doc4.xml","form_type":"4"}},{"id":1867905,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:42:26.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6652,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867904,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2023-06-06T01:42:26.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":11045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11045,"derivative":{"exercise_price":23.9,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":11045},"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867903,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:42:26.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867902,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:42:26.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":false,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867901,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:42:26.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":false,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867900,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:42:26.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":18002,"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867899,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:42:26.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":true,"shares":6391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":9450,"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1867898,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:42:26.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":true,"shares":3059,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":3059,"source":{"system":"sec-edgar","filing":"0001209191-23-034697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034697/doc4.xml","form_type":"4"}},{"id":1924709,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-05T20:34:25.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in 12 equal monthly installments, provided that the reporting person remained in continuous service with the issuer through each vesting date, and became fully exercisable on June 12, 2014."}],"balance_after":0,"derivative":{"exercise_price":29.9,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-23-023336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123023336/doc4.xml","form_type":"4"}},{"id":1924708,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:34:25.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":40.72,"value":285040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10147,"source":{"system":"sec-edgar","filing":"0001209191-23-023336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123023336/doc4.xml","form_type":"4"}},{"id":1924707,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-05T20:34:25.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":7000,"price":29.9,"value":209300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":17147,"source":{"system":"sec-edgar","filing":"0001209191-23-023336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919123023336/doc4.xml","form_type":"4"}},{"id":2054023,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-17T22:17:32.000Z","date":"2023-01-12","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.01,"expiration_date":"2023-06-06","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-003554","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123003554/doc4.xml","form_type":"4"}},{"id":2054022,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T22:17:32.000Z","date":"2023-01-12","kind":"sale","acquired":false,"shares":12500,"price":18.25,"value":228125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-003554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123003554/doc4.xml","form_type":"4"}},{"id":2054021,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-17T22:17:32.000Z","date":"2023-01-12","kind":"exercise","acquired":true,"shares":12500,"price":17.01,"value":212625.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-23-003554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123003554/doc4.xml","form_type":"4"}},{"id":2220191,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T23:16:21.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":42087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 24, 2022 will become vested on the earlier of (i) June 24, 2023 or (ii) the business day prior to the date of the 2023 annual meeting of stockholders."}],"balance_after":42087,"derivative":{"exercise_price":8.53,"exercise_date":"2023-06-08","expiration_date":"2032-06-24","underlying":"Common Stock","underlying_shares":42087},"source":{"system":"sec-edgar","filing":"0001562180-22-005383","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218022005383/primarydocument.xml","form_type":"4"}},{"id":2238132,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T00:17:51.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":8552,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-22-035662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035662/doc4.xml","form_type":"4"}},{"id":2238131,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2022-06-10T00:17:51.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":14368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":14368,"derivative":{"exercise_price":18.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":14368},"source":{"system":"sec-edgar","filing":"0001209191-22-035662","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035662/doc4.xml","form_type":"4"}},{"id":2238812,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:18:20.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":8225,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8225,"derivative":{"exercise_price":59.39,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":8225},"source":{"system":"sec-edgar","filing":"0001209191-22-035215","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919122035215/doc4.xml","form_type":"4"}},{"id":2238811,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T23:18:20.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":1160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":10147,"source":{"system":"sec-edgar","filing":"0001209191-22-035215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919122035215/doc4.xml","form_type":"4"}},{"id":2242494,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T22:07:11.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2023 annual stockholder meeting."}],"balance_after":17000,"derivative":{"exercise_price":23.51,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-22-034648","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122034648/doc4.xml","form_type":"4"}},{"id":2656306,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-24T20:38:48.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6391,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-21-043035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043035/doc4.xml","form_type":"4"}},{"id":2656305,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2021-06-24T20:38:48.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":11637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11637,"derivative":{"exercise_price":24.88,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":11637},"source":{"system":"sec-edgar","filing":"0001209191-21-043035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043035/doc4.xml","form_type":"4"}},{"id":2671491,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:30:22.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":7626,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7626,"derivative":{"exercise_price":60.96,"exercise_date":"2022-06-09","expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":7626},"source":{"system":"sec-edgar","filing":"0001209191-21-040079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919121040079/doc4.xml","form_type":"4"}},{"id":2671490,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-12T00:30:22.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":8987,"source":{"system":"sec-edgar","filing":"0001209191-21-040079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919121040079/doc4.xml","form_type":"4"}},{"id":2677796,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-08T20:46:34.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Company's 2022 annual stockholder meeting."}],"balance_after":17000,"derivative":{"exercise_price":16.88,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-21-038946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121038946/doc4.xml","form_type":"4"}},{"id":2977136,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T22:39:30.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011."}],"balance_after":0,"derivative":{"exercise_price":13.98,"expiration_date":"2021-06-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-058830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120058830/doc4.xml","form_type":"4"}},{"id":2977135,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T22:39:30.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":12000,"price":65.95,"value":791400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.930 to $66.015, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7921,"source":{"system":"sec-edgar","filing":"0001209191-20-058830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120058830/doc4.xml","form_type":"4"}},{"id":2977134,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-17T22:39:30.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":12000,"price":13.98,"value":167760.0,"ownership":{"direct":true},"balance_after":19921,"source":{"system":"sec-edgar","filing":"0001209191-20-058830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120058830/doc4.xml","form_type":"4"}},{"id":3091317,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:24:09.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":44991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":44991},"source":{"system":"sec-edgar","filing":"0001209191-20-040301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040301/doc4.xml","form_type":"4"}},{"id":3091316,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:24:09.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":11377,"price":0.06,"value":682.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."}],"balance_after":0,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-040301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040301/doc4.xml","form_type":"4"}},{"id":3091315,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-02T16:24:09.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":7281,"price":18,"value":131058.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"At the Effective Time, each restricted stock unit (\"RSU\") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040301/doc4.xml","form_type":"4"}},{"id":3091314,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T16:24:09.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":13194,"price":18,"value":237492.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the \"Issuer\"), Alexion\nPharmaceuticals, Inc. (\"Alexion\") and Odyssey Merger Sub Inc. (\"Merger Sub\") (the \"Merger Agreement\"), on July 2, 2020, Merger Sub merged with and\ninto the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the \"Merger\"). At the\neffective time of the Merger (the \"Effective Time\"), these shares were canceled in exchange for $18.00 per share in cash, without interest and\nsubject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040301/doc4.xml","form_type":"4"}},{"id":3100123,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-25T22:00:11.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":3059,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-20-038976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038976/doc4.xml","form_type":"4"}},{"id":3100122,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2020-06-25T22:00:11.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":5579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":5579,"derivative":{"exercise_price":52.73,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":5579},"source":{"system":"sec-edgar","filing":"0001209191-20-038976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038976/doc4.xml","form_type":"4"}},{"id":3110712,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T20:15:43.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":14167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2021 annual stockholder meeting."}],"balance_after":14167,"derivative":{"exercise_price":16.71,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14167},"source":{"system":"sec-edgar","filing":"0001209191-20-036581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919120036581/doc4.xml","form_type":"4"}},{"id":3110376,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T18:49:51.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":11377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":11377,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-036756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036756/doc4.xml","form_type":"4"}},{"id":3110375,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T18:49:51.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":7281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2021, subject to the Reporting Person's Continuous Services (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":20475,"source":{"system":"sec-edgar","filing":"0001209191-20-036756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036756/doc4.xml","form_type":"4"}},{"id":3113059,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:21:39.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":8027,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8027,"derivative":{"exercise_price":47.65,"exercise_date":"2021-06-09","expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":8027},"source":{"system":"sec-edgar","filing":"0001209191-20-036033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120036033/doc4.xml","form_type":"4"}},{"id":3113058,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T22:21:39.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":1260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2021, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":7921,"source":{"system":"sec-edgar","filing":"0001209191-20-036033","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120036033/doc4.xml","form_type":"4"}},{"id":3118280,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T01:04:41.000Z","date":"2020-06-05","kind":"sale","acquired":false,"shares":2100,"price":48.7,"value":102270.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":6661,"source":{"system":"sec-edgar","filing":"0001209191-20-035169","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919120035169/doc4.xml","form_type":"4"}},{"id":3315476,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:01:43.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2021-06-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-002595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002595/doc4.xml","form_type":"4"}},{"id":3315475,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-08T23:01:43.000Z","date":"2020-01-07","kind":"sale","acquired":false,"shares":10000,"price":42.19,"value":421900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-002595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002595/doc4.xml","form_type":"4"}},{"id":3315474,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-08T23:01:43.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":10000,"price":1.75,"value":17500.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-20-002595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002595/doc4.xml","form_type":"4"}},{"id":3416328,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-12T20:21:26.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":10000,"price":11.22,"value":112200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-049309","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919119049309/doc4.xml","form_type":"4"}},{"id":3459237,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-18T20:55:21.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in a series of 3 successive equal annual installments measured from July 17, 2019. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase.  The shares will vest in full upon a change in control, as that term is defined in the Issuer's 2019 Equity Incentive Plan."}],"balance_after":17000,"derivative":{"exercise_price":15,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-19-042657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919119042657/doc4.xml","form_type":"4"}},{"id":3476272,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T21:09:19.000Z","date":"2019-06-26","kind":"grant","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":25.24,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-039522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119039522/doc4.xml","form_type":"4"}},{"id":3487585,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T17:14:55.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":6991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6991,"derivative":{"exercise_price":26.09,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":6991},"source":{"system":"sec-edgar","filing":"0001209191-19-037435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037435/doc4.xml","form_type":"4"}},{"id":3487584,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T17:14:55.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":4194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001209191-19-037435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037435/doc4.xml","form_type":"4"}},{"id":3498521,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T20:27:24.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":8437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":8437,"derivative":{"exercise_price":43.54,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001209191-19-035072","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919119035072/doc4.xml","form_type":"4"}},{"id":3498520,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T20:27:24.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":4134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2020, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":8761,"source":{"system":"sec-edgar","filing":"0001209191-19-035072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919119035072/doc4.xml","form_type":"4"}},{"id":3506614,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2019-05-31T18:26:15.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 30, 2020, on the one year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":4.97,"expiration_date":"2026-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-033719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919119033719/doc4.xml","form_type":"4"}},{"id":3697589,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-11T21:32:09.000Z","date":"2019-01-09","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.16,"expiration_date":"2019-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-003427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119003427/doc4.xml","form_type":"4"}},{"id":3697588,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-11T21:32:09.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":10000,"price":20.0041,"value":200041.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-003427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119003427/doc4.xml","form_type":"4"}},{"id":3697587,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-11T21:32:09.000Z","date":"2019-01-09","kind":"exercise","acquired":true,"shares":10000,"price":2.16,"value":21600.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-003427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119003427/doc4.xml","form_type":"4"}},{"id":3858886,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-30T21:38:19.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":4.36,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-044443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919118044443/doc4.xml","form_type":"4"}},{"id":3858885,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-30T21:38:19.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-18-044443","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919118044443/doc4.xml","form_type":"4"}},{"id":3892171,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T23:12:34.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":4693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date."}],"balance_after":4693,"derivative":{"exercise_price":38.35,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":4693},"source":{"system":"sec-edgar","filing":"0001209191-18-038189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919118038189/doc4.xml","form_type":"4"}},{"id":3892170,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-15T23:12:34.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest on June 3, 2019, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":4627,"source":{"system":"sec-edgar","filing":"0001209191-18-038189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365619/000120919118038189/doc4.xml","form_type":"4"}},{"id":3900445,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":37268,"kind":"person","name":"Brege Laura","position":1,"cik":"0001365619","reported_name":"Brege Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-06-08T21:05:32.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":17.52,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-18-000910","document":"form4-06082018_020616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000910/form4-06082018_020616.xml","form_type":"4"}}],"next_cursor":"2018-06-08T21:05:32.000000Z,3900445"}